Invivo CAR-T

BIOLOGICAL2 trials

Sponsors

Chongqing Precision Biotech Co., Ltd

Conditions

B Cell Non-Hodgkin's LymphomaB-Acute Lymphoblastic LeukemiaMultiple MyelomaRelapsed or Refractory Multiple Myeloma (RRMM)

Phase 1

In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies

RecruitingNCT07239323

Chongqing Precision Biotech Co., LtdB-Acute Lymphoblastic Leukemia, B Cell Non-Hodgkin's Lymphoma, Multiple Myeloma

Start: 2025-07-01End: 2028-12-31Target: 24Updated: 2025-11-20

In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma

RecruitingNCT07715630

Chongqing Precision Biotech Co., LtdRelapsed or Refractory Multiple Myeloma (RRMM)

Start: 2026-07-31End: 2028-07-31Target: 15Updated: 2026-07-20